{"nct_id":"NCT05060016","title":"A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-12-01","start_date_type":"ACTUAL","primary_completion_date":"2026-04-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-04-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AMGN"]}